Verona Pharma (VRNA) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free VRNA Stock Alerts $14.79 -0.16 (-1.07%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Verona Pharma Short Interest DataCurrent Short Volume6,070,000 sharesPrevious Short Volume6,560,000 sharesChange Vs. Previous Month-7.47%Dollar Volume Sold Short$95.91 millionShort Interest Ratio / Days to Cover13.8Last Record DateApril 15, 2024Outstanding Shares80,820,000 sharesPercentage of Shares Shorted7.51%Today's Trading Volume328,543 sharesAverage Trading Volume492,258 sharesToday's Volume Vs. Average67% Short Selling Verona Pharma ? Sign up to receive the latest short interest report for Verona Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVRNA Short Interest Over TimeVRNA Days to Cover Over TimeVRNA Percentage of Float Shorted Over Time Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details Verona Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,070,000 shares $95.91 million -7.5%N/A13.8 $15.80 3/31/20246,560,000 shares $105.55 million +2.5%N/A13.3 $16.09 3/15/20246,400,000 shares $100.16 million +1.0%N/A11.7 $15.65 2/29/20246,340,000 shares $109.17 million -5.2%11.5%10.8 $17.22 2/15/20246,690,000 shares $112.06 million -2.2%12.2%11.6 $16.75 1/31/20246,840,000 shares $125.51 million +0.7%N/A12.5 $18.35 Get the Latest News and Ratings for VRNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verona Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/20246,790,000 shares $121.81 million +4.0%N/A11.9 $17.94 12/31/20236,530,000 shares $129.82 million +4.7%N/A11.9 $19.88 12/15/20236,240,000 shares $107.76 million -4.2%N/A13.3 $17.27 11/30/20236,510,000 shares $88.02 million +3.7%N/A16.7 $13.52 11/15/20236,280,000 shares $90.12 million +4.2%N/A17.8 $14.35 10/31/20236,030,000 shares $84.12 million +53.1%N/A17.3 $13.95 10/15/20233,940,000 shares $52.84 million -14.2%N/A12.7 $13.41 9/30/20234,590,000 shares $74.82 million +4.1%N/A15.1 $16.30 9/15/20234,410,000 shares $77.66 million +14.3%N/A13.9 $17.61 8/31/20233,860,000 shares $75.00 million +1.6%N/A11.2 $19.43 8/15/20233,800,000 shares $69.05 million +8.9%N/A10.5 $18.17 7/31/20233,490,000 shares $77.09 million +3.9%N/A8.7 $22.09 7/15/20233,360,000 shares $74.22 million +0.3%N/A8.1 $22.09 6/30/20233,350,000 shares $70.82 million +24.1%5.8%7 $21.14 6/15/20232,700,000 shares $57.02 million +1.9%4.7%5.3 $21.12 5/31/20232,650,000 shares $57.03 million +13.3%4.6%5.2 $21.52 5/15/20232,340,000 shares $48.95 million +2.2%4.1%4.3 $20.92 4/30/20232,290,000 shares $47.98 million +21.8%N/A4.1 $20.95 4/15/20231,880,000 shares $40.36 million +3.9%N/A3.1 $21.47 3/31/20231,810,000 shares $36.34 million +15.3%N/A3.1 $20.08 3/15/20231,570,000 shares $28.54 million +4.0%2.9%1.5 $18.18 2/28/20231,510,000 shares $32.37 million -7.4%2.8%1.4 $21.44 2/15/20231,630,000 shares $35.52 million +1.2%3.0%1.6 $21.79 1/31/20231,610,000 shares $35.48 million +7.3%3.1%1.7 $22.04 1/15/20231,500,000 shares $35.88 million +20.0%2.9%1.7 $23.92 12/30/20221,250,000 shares $32.66 million +95.0%2.4%1.5 $26.13 12/15/2022640,900 shares $8.21 million -4.7%1.2%0.9 $12.81 11/30/2022672,800 shares $8.68 million -14.5%1.3%2.8 $12.90 11/15/2022786,700 shares $9.73 million -8.0%1.5%3.3 $12.37 10/31/2022855,200 shares $10.95 million +12.3%N/A1.9 $12.80 10/15/2022761,500 shares $7.62 million +25.7%1.6%0.8 $10.01 9/30/2022605,900 shares $6.19 million -3.3%1.2%0.6 $10.22 9/15/2022626,500 shares $6.77 million +19.0%1.3%0.7 $10.80 8/31/2022526,300 shares $5.48 million -30.8%1.1%0.6 $10.42Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now VRNA Short Interest - Frequently Asked Questions What is Verona Pharma's current short interest? Short interest is the volume of Verona Pharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 6,070,000 shares of VRNA short. Learn More on Verona Pharma's current short interest. What is a good short interest ratio for Verona Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRNA shares currently have a short interest ratio of 14.0. Learn More on Verona Pharma's short interest ratio. Which institutional investors are shorting Verona Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Verona Pharma: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Verona Pharma's short interest increasing or decreasing? Verona Pharma saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 6,070,000 shares, a decrease of 7.5% from the previous total of 6,560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Verona Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Verona Pharma: Ligand Pharmaceuticals Incorporated (4.98%), Pacira BioSciences, Inc. (7.42%), Ironwood Pharmaceuticals, Inc. (13.96%), Collegium Pharmaceutical, Inc. (22.86%), Xencor, Inc. (10.09%), Spyre Therapeutics, Inc. (10.55%), Belite Bio, Inc (0.12%), Mirum Pharmaceuticals, Inc. (18.21%), Kiniksa Pharmaceuticals, Ltd. (5.13%), Gyre Therapeutics, Inc. (1.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Verona Pharma stock? Short selling VRNA is an investing strategy that aims to generate trading profit from Verona Pharma as its price is falling. VRNA shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Verona Pharma? A short squeeze for Verona Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRNA, which in turn drives the price of the stock up even further. How often is Verona Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRNA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LGND Short Squeeze PCRX Short Squeeze IRWD Short Squeeze COLL Short Squeeze XNCR Short Squeeze SYRE Short Squeeze BLTE Short Squeeze MIRM Short Squeeze KNSA Short Squeeze GYRE Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRNA) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryThe asset beating inflation by 4xColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society